Health Sciences Acquisitions Corpor... (HSAQ)
|52 Week Range||9.41-13.8|
|1y Target Est||-|
|DCF Unlevered||HSAQ DCF ->|
|DCF Levered||HSAQ LDCF ->|
|Debt / Equity||-105.75%||Sell|
Upgrades & Downgrades
Latest HSAQ news
Health Sciences Acquisitions Corporation 2 Announces Closing of Upsized $160 Million Initial Public ...
6 August 2020
Health Sciences Acquisitions Corporation 2 (Nasdaq: HSAQ, the "Company" or "HSAC 2") announced today that it closed its initial public offering of 16,000,000 ordinary shares, which included the full e...
Health Sciences Acquisitions Corporation 2 does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or related business combination with one or more businesses in the biopharma and medical technology sectors in North America or Europe. Health Sciences Acquisitions Corporation 2 was incorporated in 2020 and is based in New York, New York.
Stock Value >
Financial Summary > Financial Statements > Financial Quarter Statements > Ratios Analysis > Dupont Analysis > Free Cash Flow > Operating Data > Balance Sheet Data >